Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(high grade serous ovarian cancer). Showing records 1 – 30 of 70597 total matches.

[1] [2] [3] [4] [5] … [2354]

Search Limiters

Last 2 Years | English Only

Degrees

Languages

Country

▼ Search Limiters


University of Sydney

1. Moujaber, Tania. Molecular Pathways in Low-Grade Serous Ovarian Cancer .

Degree: 2019, University of Sydney

 Low-grade serous cancer (LGSC) is a distinct subtype of ovarian cancer (OC), characterised by younger age at diagnosis and low chemotherapy response rates compared with… (more)

Subjects/Keywords: low-grade serous ovarian cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Moujaber, T. (2019). Molecular Pathways in Low-Grade Serous Ovarian Cancer . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/21999

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Moujaber, Tania. “Molecular Pathways in Low-Grade Serous Ovarian Cancer .” 2019. Thesis, University of Sydney. Accessed May 08, 2021. http://hdl.handle.net/2123/21999.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Moujaber, Tania. “Molecular Pathways in Low-Grade Serous Ovarian Cancer .” 2019. Web. 08 May 2021.

Vancouver:

Moujaber T. Molecular Pathways in Low-Grade Serous Ovarian Cancer . [Internet] [Thesis]. University of Sydney; 2019. [cited 2021 May 08]. Available from: http://hdl.handle.net/2123/21999.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Moujaber T. Molecular Pathways in Low-Grade Serous Ovarian Cancer . [Thesis]. University of Sydney; 2019. Available from: http://hdl.handle.net/2123/21999

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

2. Everitt, Gemma Louise Ann. The inflammatory infiltrate of high-grade serous carcinoma omental metastasis.

Degree: PhD, 2014, Queen Mary, University of London

 The aim of this thesis is to investigate the role of inflammatory infiltrates and chemokines in metastasis of high-grade serous ovarian cancer, HGSC, to the… (more)

Subjects/Keywords: 616.99; high-grade serous ovarian cancer; chemokines; CD68+ macrophages; omental metastases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Everitt, G. L. A. (2014). The inflammatory infiltrate of high-grade serous carcinoma omental metastasis. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/8038 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.658696

Chicago Manual of Style (16th Edition):

Everitt, Gemma Louise Ann. “The inflammatory infiltrate of high-grade serous carcinoma omental metastasis.” 2014. Doctoral Dissertation, Queen Mary, University of London. Accessed May 08, 2021. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8038 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.658696.

MLA Handbook (7th Edition):

Everitt, Gemma Louise Ann. “The inflammatory infiltrate of high-grade serous carcinoma omental metastasis.” 2014. Web. 08 May 2021.

Vancouver:

Everitt GLA. The inflammatory infiltrate of high-grade serous carcinoma omental metastasis. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2014. [cited 2021 May 08]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8038 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.658696.

Council of Science Editors:

Everitt GLA. The inflammatory infiltrate of high-grade serous carcinoma omental metastasis. [Doctoral Dissertation]. Queen Mary, University of London; 2014. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8038 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.658696


University of New South Wales

3. Williams, Rebekka. ABCA1 promotes aggressive characteristics in epithelial ovarian cancer.

Degree: Women's & Children's Health, 2016, University of New South Wales

 Epithelial ovarian cancer (EOC) is a devastating disease, which accounts for a large proportion of gynaecological cancer-related deaths. Poor survival is largely due to late… (more)

Subjects/Keywords: Spehroids; Ovarian Cancer; ABCA1; 3D culture; High Grade Serous

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Williams, R. (2016). ABCA1 promotes aggressive characteristics in epithelial ovarian cancer. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/57533 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:43625/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Williams, Rebekka. “ABCA1 promotes aggressive characteristics in epithelial ovarian cancer.” 2016. Doctoral Dissertation, University of New South Wales. Accessed May 08, 2021. http://handle.unsw.edu.au/1959.4/57533 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:43625/SOURCE02?view=true.

MLA Handbook (7th Edition):

Williams, Rebekka. “ABCA1 promotes aggressive characteristics in epithelial ovarian cancer.” 2016. Web. 08 May 2021.

Vancouver:

Williams R. ABCA1 promotes aggressive characteristics in epithelial ovarian cancer. [Internet] [Doctoral dissertation]. University of New South Wales; 2016. [cited 2021 May 08]. Available from: http://handle.unsw.edu.au/1959.4/57533 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:43625/SOURCE02?view=true.

Council of Science Editors:

Williams R. ABCA1 promotes aggressive characteristics in epithelial ovarian cancer. [Doctoral Dissertation]. University of New South Wales; 2016. Available from: http://handle.unsw.edu.au/1959.4/57533 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:43625/SOURCE02?view=true

4. Heong, Valerie Yue Ming. Targeted approaches to C5 high-grade serous ovarian cancer through novel patient derived xenografts.

Degree: 2017, University of Melbourne

 Epithelial ovarian carcinoma (EOC) is the fifth most common cause of cancer death in western women. It can be classified into five main histological subtypes… (more)

Subjects/Keywords: ovarian cancer; high grade serous ovarian carcinoma; patient derived xenograft; therapeutics; gene expression; molecular subtypes

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Heong, V. Y. M. (2017). Targeted approaches to C5 high-grade serous ovarian cancer through novel patient derived xenografts. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/194905

Chicago Manual of Style (16th Edition):

Heong, Valerie Yue Ming. “Targeted approaches to C5 high-grade serous ovarian cancer through novel patient derived xenografts.” 2017. Doctoral Dissertation, University of Melbourne. Accessed May 08, 2021. http://hdl.handle.net/11343/194905.

MLA Handbook (7th Edition):

Heong, Valerie Yue Ming. “Targeted approaches to C5 high-grade serous ovarian cancer through novel patient derived xenografts.” 2017. Web. 08 May 2021.

Vancouver:

Heong VYM. Targeted approaches to C5 high-grade serous ovarian cancer through novel patient derived xenografts. [Internet] [Doctoral dissertation]. University of Melbourne; 2017. [cited 2021 May 08]. Available from: http://hdl.handle.net/11343/194905.

Council of Science Editors:

Heong VYM. Targeted approaches to C5 high-grade serous ovarian cancer through novel patient derived xenografts. [Doctoral Dissertation]. University of Melbourne; 2017. Available from: http://hdl.handle.net/11343/194905


Queens University

5. Au, Katrina. Role of STAT1 and CXCL10 in the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer .

Degree: Biomedical and Molecular Sciences, 2016, Queens University

High-grade serous ovarian cancer (HGSC) is the most prevalent epithelial ovarian cancer characterized by late detection, metastasis and resistance to chemotherapy. Previous studies on the… (more)

Subjects/Keywords: CXCL10 ; CD8+ T Cells ; Cancer ; STAT1 ; Tumour Immune Microenvironment ; Biomarkers ; High-Grade Serous Ovarian Cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Au, K. (2016). Role of STAT1 and CXCL10 in the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/14676

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Au, Katrina. “Role of STAT1 and CXCL10 in the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer .” 2016. Thesis, Queens University. Accessed May 08, 2021. http://hdl.handle.net/1974/14676.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Au, Katrina. “Role of STAT1 and CXCL10 in the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer .” 2016. Web. 08 May 2021.

Vancouver:

Au K. Role of STAT1 and CXCL10 in the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer . [Internet] [Thesis]. Queens University; 2016. [cited 2021 May 08]. Available from: http://hdl.handle.net/1974/14676.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Au K. Role of STAT1 and CXCL10 in the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer . [Thesis]. Queens University; 2016. Available from: http://hdl.handle.net/1974/14676

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of New South Wales

6. Baker, Laura. Inhibitor of Differentiation 4: a new player in the DNA damage repair pathway in basal-like breast cancer.

Degree: Garvan Institute of Medical Research, 2017, University of New South Wales

 Basal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Poor survival… (more)

Subjects/Keywords: Basal-like breast cancer; Inhibitor of Differentiation 4; ID4; high-grade serous ovarian cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baker, L. (2017). Inhibitor of Differentiation 4: a new player in the DNA damage repair pathway in basal-like breast cancer. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/57661 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:44483/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Baker, Laura. “Inhibitor of Differentiation 4: a new player in the DNA damage repair pathway in basal-like breast cancer.” 2017. Doctoral Dissertation, University of New South Wales. Accessed May 08, 2021. http://handle.unsw.edu.au/1959.4/57661 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:44483/SOURCE02?view=true.

MLA Handbook (7th Edition):

Baker, Laura. “Inhibitor of Differentiation 4: a new player in the DNA damage repair pathway in basal-like breast cancer.” 2017. Web. 08 May 2021.

Vancouver:

Baker L. Inhibitor of Differentiation 4: a new player in the DNA damage repair pathway in basal-like breast cancer. [Internet] [Doctoral dissertation]. University of New South Wales; 2017. [cited 2021 May 08]. Available from: http://handle.unsw.edu.au/1959.4/57661 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:44483/SOURCE02?view=true.

Council of Science Editors:

Baker L. Inhibitor of Differentiation 4: a new player in the DNA damage repair pathway in basal-like breast cancer. [Doctoral Dissertation]. University of New South Wales; 2017. Available from: http://handle.unsw.edu.au/1959.4/57661 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:44483/SOURCE02?view=true


University of Western Ontario

7. Peart, Teresa M. Distinct roles of BMP and LKB1/AMPK signalling impacting ovarian cancer spheroid biology.

Degree: 2014, University of Western Ontario

High-grade serous (HGS) carcinoma, the most prevalent and most deadly subtype of epithelial ovarian cancer (EOC), presents unique therapeutic challenges since the majority of cases… (more)

Subjects/Keywords: high-grade serous ovarian cancer; BMP signalling; LKB1/AMPK signalling; multicellular spheroids; patient samples; Cancer Biology; Cell Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Peart, T. M. (2014). Distinct roles of BMP and LKB1/AMPK signalling impacting ovarian cancer spheroid biology. (Thesis). University of Western Ontario. Retrieved from https://ir.lib.uwo.ca/etd/1993

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Peart, Teresa M. “Distinct roles of BMP and LKB1/AMPK signalling impacting ovarian cancer spheroid biology.” 2014. Thesis, University of Western Ontario. Accessed May 08, 2021. https://ir.lib.uwo.ca/etd/1993.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Peart, Teresa M. “Distinct roles of BMP and LKB1/AMPK signalling impacting ovarian cancer spheroid biology.” 2014. Web. 08 May 2021.

Vancouver:

Peart TM. Distinct roles of BMP and LKB1/AMPK signalling impacting ovarian cancer spheroid biology. [Internet] [Thesis]. University of Western Ontario; 2014. [cited 2021 May 08]. Available from: https://ir.lib.uwo.ca/etd/1993.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Peart TM. Distinct roles of BMP and LKB1/AMPK signalling impacting ovarian cancer spheroid biology. [Thesis]. University of Western Ontario; 2014. Available from: https://ir.lib.uwo.ca/etd/1993

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Monash University

8. KAMPAN, NIRMALA CHANDRALEGA. Investigating the role of immune responses in preventing relapse in women with high-grade serous ovarian cancer (HGSOC).

Degree: Medicine, Nursing and Health Sciences, 2018, Monash University

 Development of novel diagnostic and prognostic clinical tests or models is critical to help stratify patients with ovarian cancer for an improved disease outcome, particular… (more)

Subjects/Keywords: Medicine; Immunology; Cancer; Obstetrics and Gynaecology; ovarian cancer; relapse; immune responses; inflammation; immunosuppression; TNFR2 receptor; Interleukin 6; high-grade serous

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

KAMPAN, N. C. (2018). Investigating the role of immune responses in preventing relapse in women with high-grade serous ovarian cancer (HGSOC). (Thesis). Monash University. Retrieved from https://doi.org/10.4225/03/5ab2db66a647c

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

KAMPAN, NIRMALA CHANDRALEGA. “Investigating the role of immune responses in preventing relapse in women with high-grade serous ovarian cancer (HGSOC).” 2018. Thesis, Monash University. Accessed May 08, 2021. https://doi.org/10.4225/03/5ab2db66a647c.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

KAMPAN, NIRMALA CHANDRALEGA. “Investigating the role of immune responses in preventing relapse in women with high-grade serous ovarian cancer (HGSOC).” 2018. Web. 08 May 2021.

Vancouver:

KAMPAN NC. Investigating the role of immune responses in preventing relapse in women with high-grade serous ovarian cancer (HGSOC). [Internet] [Thesis]. Monash University; 2018. [cited 2021 May 08]. Available from: https://doi.org/10.4225/03/5ab2db66a647c.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

KAMPAN NC. Investigating the role of immune responses in preventing relapse in women with high-grade serous ovarian cancer (HGSOC). [Thesis]. Monash University; 2018. Available from: https://doi.org/10.4225/03/5ab2db66a647c

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Queensland University of Technology

9. Silva, Munasinghage Lakmali. Determination of the kallikrein-related peptidase 7 degradome and Transciptome in ovarian cancer.

Degree: 2016, Queensland University of Technology

Ovarian cancer is the leading cause of cancer-related death in women, and the need for curative treatments is urgent. This study characterised an enzyme associated… (more)

Subjects/Keywords: Cancer; Degradome; Extracellular; High-grade serous ovarian; Kallikrein-related peptidase; Matrix metalloprotease; Proteomics; Thrombospondin; Transcriptomics; Microenvironment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Silva, M. L. (2016). Determination of the kallikrein-related peptidase 7 degradome and Transciptome in ovarian cancer. (Thesis). Queensland University of Technology. Retrieved from https://eprints.qut.edu.au/92869/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Silva, Munasinghage Lakmali. “Determination of the kallikrein-related peptidase 7 degradome and Transciptome in ovarian cancer.” 2016. Thesis, Queensland University of Technology. Accessed May 08, 2021. https://eprints.qut.edu.au/92869/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Silva, Munasinghage Lakmali. “Determination of the kallikrein-related peptidase 7 degradome and Transciptome in ovarian cancer.” 2016. Web. 08 May 2021.

Vancouver:

Silva ML. Determination of the kallikrein-related peptidase 7 degradome and Transciptome in ovarian cancer. [Internet] [Thesis]. Queensland University of Technology; 2016. [cited 2021 May 08]. Available from: https://eprints.qut.edu.au/92869/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Silva ML. Determination of the kallikrein-related peptidase 7 degradome and Transciptome in ovarian cancer. [Thesis]. Queensland University of Technology; 2016. Available from: https://eprints.qut.edu.au/92869/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Illinois – Chicago

10. Jia Xie (247149). Fractalkine Receptor Regulates Cellular Response to X-Ray Radiation in Ovarian Cancer Cells.

Degree: 2016, University of Illinois – Chicago

High-grade serous carcinoma (HGSC) is the most common and lethal histotype of ovarian cancer. Radiation is usually used as a second-line treatment against the disease.… (more)

Subjects/Keywords: Uncategorized; high-grade serous ovarian cancer; ionizing radiation; fractalkine receptor; DNA damage repair; reactive oxygen species

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

(247149), J. X. (2016). Fractalkine Receptor Regulates Cellular Response to X-Ray Radiation in Ovarian Cancer Cells. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/20256

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

(247149), Jia Xie. “Fractalkine Receptor Regulates Cellular Response to X-Ray Radiation in Ovarian Cancer Cells.” 2016. Thesis, University of Illinois – Chicago. Accessed May 08, 2021. http://hdl.handle.net/10027/20256.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

(247149), Jia Xie. “Fractalkine Receptor Regulates Cellular Response to X-Ray Radiation in Ovarian Cancer Cells.” 2016. Web. 08 May 2021.

Vancouver:

(247149) JX. Fractalkine Receptor Regulates Cellular Response to X-Ray Radiation in Ovarian Cancer Cells. [Internet] [Thesis]. University of Illinois – Chicago; 2016. [cited 2021 May 08]. Available from: http://hdl.handle.net/10027/20256.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

(247149) JX. Fractalkine Receptor Regulates Cellular Response to X-Ray Radiation in Ovarian Cancer Cells. [Thesis]. University of Illinois – Chicago; 2016. Available from: http://hdl.handle.net/10027/20256

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

11. Jiménez Sánchez, Alejandro. Characterisation of the tumour microenvironment in ovarian cancer.

Degree: PhD, 2019, University of Cambridge

 The tumour microenvironment comprises the non-cancerous cells present in the tumour mass (fibroblasts, endothelial, and immune cells), as well as signalling molecules and extracellular matrix.… (more)

Subjects/Keywords: 616.99; Tumour microenvironment; High grade serous ovarian cancer; Bioinformatics; Genomics; Systems biology; Computational biology; Cancer; Cancer immunology; Chemotherapy; Immunotherapy; Tumour heterogeneity; Personalised medicine; Computational method development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jiménez Sánchez, A. (2019). Characterisation of the tumour microenvironment in ovarian cancer. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.35250 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.763876

Chicago Manual of Style (16th Edition):

Jiménez Sánchez, Alejandro. “Characterisation of the tumour microenvironment in ovarian cancer.” 2019. Doctoral Dissertation, University of Cambridge. Accessed May 08, 2021. https://doi.org/10.17863/CAM.35250 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.763876.

MLA Handbook (7th Edition):

Jiménez Sánchez, Alejandro. “Characterisation of the tumour microenvironment in ovarian cancer.” 2019. Web. 08 May 2021.

Vancouver:

Jiménez Sánchez A. Characterisation of the tumour microenvironment in ovarian cancer. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 May 08]. Available from: https://doi.org/10.17863/CAM.35250 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.763876.

Council of Science Editors:

Jiménez Sánchez A. Characterisation of the tumour microenvironment in ovarian cancer. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://doi.org/10.17863/CAM.35250 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.763876


University of Cambridge

12. Jiménez Sánchez, Alejandro. Characterisation of the Tumour Microenvironment in Ovarian Cancer.

Degree: PhD, 2019, University of Cambridge

 The tumour microenvironment comprises the non-cancerous cells present in the tumour mass (fibroblasts, endothelial, and immune cells), as well as signalling molecules and extracellular matrix.… (more)

Subjects/Keywords: Tumour microenvironment; High grade serous ovarian cancer; Bioinformatics; Genomics; Systems biology; Computational biology; Cancer; Cancer immunology; Chemotherapy; Immunotherapy; Tumour heterogeneity; Personalised medicine; Computational method development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jiménez Sánchez, A. (2019). Characterisation of the Tumour Microenvironment in Ovarian Cancer. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/287935https://www.repository.cam.ac.uk/bitstream/1810/287935/3/c233f0aa-7a25-4908-b9f3-579fb845aeeb_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/5/c233f0aa-7a25-4908-b9f3-579fb845aeeb.zip ; https://www.repository.cam.ac.uk/bitstream/1810/287935/6/AJS_PhDthesis_corrected.pdf.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/7/AJS_PhDthesis_corrected.pdf.jpg

Chicago Manual of Style (16th Edition):

Jiménez Sánchez, Alejandro. “Characterisation of the Tumour Microenvironment in Ovarian Cancer.” 2019. Doctoral Dissertation, University of Cambridge. Accessed May 08, 2021. https://www.repository.cam.ac.uk/handle/1810/287935https://www.repository.cam.ac.uk/bitstream/1810/287935/3/c233f0aa-7a25-4908-b9f3-579fb845aeeb_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/5/c233f0aa-7a25-4908-b9f3-579fb845aeeb.zip ; https://www.repository.cam.ac.uk/bitstream/1810/287935/6/AJS_PhDthesis_corrected.pdf.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/7/AJS_PhDthesis_corrected.pdf.jpg.

MLA Handbook (7th Edition):

Jiménez Sánchez, Alejandro. “Characterisation of the Tumour Microenvironment in Ovarian Cancer.” 2019. Web. 08 May 2021.

Vancouver:

Jiménez Sánchez A. Characterisation of the Tumour Microenvironment in Ovarian Cancer. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 May 08]. Available from: https://www.repository.cam.ac.uk/handle/1810/287935https://www.repository.cam.ac.uk/bitstream/1810/287935/3/c233f0aa-7a25-4908-b9f3-579fb845aeeb_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/5/c233f0aa-7a25-4908-b9f3-579fb845aeeb.zip ; https://www.repository.cam.ac.uk/bitstream/1810/287935/6/AJS_PhDthesis_corrected.pdf.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/7/AJS_PhDthesis_corrected.pdf.jpg.

Council of Science Editors:

Jiménez Sánchez A. Characterisation of the Tumour Microenvironment in Ovarian Cancer. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://www.repository.cam.ac.uk/handle/1810/287935https://www.repository.cam.ac.uk/bitstream/1810/287935/3/c233f0aa-7a25-4908-b9f3-579fb845aeeb_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/5/c233f0aa-7a25-4908-b9f3-579fb845aeeb.zip ; https://www.repository.cam.ac.uk/bitstream/1810/287935/6/AJS_PhDthesis_corrected.pdf.txt ; https://www.repository.cam.ac.uk/bitstream/1810/287935/7/AJS_PhDthesis_corrected.pdf.jpg


University of Cambridge

13. Hall, Douglas. Phenotypic heterogeneity in high-grade serous ovarian cancer : evidence for a stochastic model of proliferation.

Degree: PhD, 2017, University of Cambridge

High-grade serous ovarian cancer (HGSOC) represents the largest and most lethal subtype of ovarian cancers. Chemotherapy is effective at depleting these tumours, sometimes eliminating all… (more)

Subjects/Keywords: ovarian cancer; HGSOC; high-grade serous; stochastic; proliferation; cancer stem cells; stem cells; PDX; xenografts; subcutaneous; EpCAM; slow-cycling; apoptosis; lineage tracing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hall, D. (2017). Phenotypic heterogeneity in high-grade serous ovarian cancer : evidence for a stochastic model of proliferation. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.38510 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.774843

Chicago Manual of Style (16th Edition):

Hall, Douglas. “Phenotypic heterogeneity in high-grade serous ovarian cancer : evidence for a stochastic model of proliferation.” 2017. Doctoral Dissertation, University of Cambridge. Accessed May 08, 2021. https://doi.org/10.17863/CAM.38510 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.774843.

MLA Handbook (7th Edition):

Hall, Douglas. “Phenotypic heterogeneity in high-grade serous ovarian cancer : evidence for a stochastic model of proliferation.” 2017. Web. 08 May 2021.

Vancouver:

Hall D. Phenotypic heterogeneity in high-grade serous ovarian cancer : evidence for a stochastic model of proliferation. [Internet] [Doctoral dissertation]. University of Cambridge; 2017. [cited 2021 May 08]. Available from: https://doi.org/10.17863/CAM.38510 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.774843.

Council of Science Editors:

Hall D. Phenotypic heterogeneity in high-grade serous ovarian cancer : evidence for a stochastic model of proliferation. [Doctoral Dissertation]. University of Cambridge; 2017. Available from: https://doi.org/10.17863/CAM.38510 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.774843


University of Western Ontario

14. Perampalam, Pirunthan. Functional Role of DREAM and DYRK1A in High-Grade Serous Ovarian Cancer Cell Dormancy.

Degree: 2021, University of Western Ontario

High-grade serous ovarian cancer (HGSOC) is the most common form of ovarian cancer. The majority of women are disproportionately diagnosed at an advanced stage (stage… (more)

Subjects/Keywords: high-grade serous ovarian cancer; dormancy; metastasis; spheroids; DREAM; DYRK1A; Cancer Biology; Medical Cell Biology; Obstetrics and Gynecology; Oncology; Pathology; Translational Medical Research

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Perampalam, P. (2021). Functional Role of DREAM and DYRK1A in High-Grade Serous Ovarian Cancer Cell Dormancy. (Thesis). University of Western Ontario. Retrieved from https://ir.lib.uwo.ca/etd/7675

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Perampalam, Pirunthan. “Functional Role of DREAM and DYRK1A in High-Grade Serous Ovarian Cancer Cell Dormancy.” 2021. Thesis, University of Western Ontario. Accessed May 08, 2021. https://ir.lib.uwo.ca/etd/7675.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Perampalam, Pirunthan. “Functional Role of DREAM and DYRK1A in High-Grade Serous Ovarian Cancer Cell Dormancy.” 2021. Web. 08 May 2021.

Vancouver:

Perampalam P. Functional Role of DREAM and DYRK1A in High-Grade Serous Ovarian Cancer Cell Dormancy. [Internet] [Thesis]. University of Western Ontario; 2021. [cited 2021 May 08]. Available from: https://ir.lib.uwo.ca/etd/7675.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Perampalam P. Functional Role of DREAM and DYRK1A in High-Grade Serous Ovarian Cancer Cell Dormancy. [Thesis]. University of Western Ontario; 2021. Available from: https://ir.lib.uwo.ca/etd/7675

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Illinois – Chicago

15. Subbulakshmi Karthikeyan (6039512). Signaling Pathways Contributing to High-Grade Serous Ovarian Cancer and Metastasis from Fallopian Tube.

Degree: 2018, University of Illinois – Chicago

 The fallopian tube epithelium (FTE) gives rise to high grade serous ovarian cancer (HGSOC), the most lethal gynecological malignancy. A mutation in p53 is reported… (more)

Subjects/Keywords: Uncategorized; High grade serous ovarian cancer; p53 mutation; Prolactin; Prolactin receptor; Spontaneous fallopian tube derived cancer model; p53 phosphorylation; Cadherins; Fallopian tube; Mutant p53 transgenic mouse model

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

(6039512), S. K. (2018). Signaling Pathways Contributing to High-Grade Serous Ovarian Cancer and Metastasis from Fallopian Tube. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/22970

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

(6039512), Subbulakshmi Karthikeyan. “Signaling Pathways Contributing to High-Grade Serous Ovarian Cancer and Metastasis from Fallopian Tube.” 2018. Thesis, University of Illinois – Chicago. Accessed May 08, 2021. http://hdl.handle.net/10027/22970.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

(6039512), Subbulakshmi Karthikeyan. “Signaling Pathways Contributing to High-Grade Serous Ovarian Cancer and Metastasis from Fallopian Tube.” 2018. Web. 08 May 2021.

Vancouver:

(6039512) SK. Signaling Pathways Contributing to High-Grade Serous Ovarian Cancer and Metastasis from Fallopian Tube. [Internet] [Thesis]. University of Illinois – Chicago; 2018. [cited 2021 May 08]. Available from: http://hdl.handle.net/10027/22970.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

(6039512) SK. Signaling Pathways Contributing to High-Grade Serous Ovarian Cancer and Metastasis from Fallopian Tube. [Thesis]. University of Illinois – Chicago; 2018. Available from: http://hdl.handle.net/10027/22970

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cambridge

16. Hall, Douglas. Phenotypic heterogeneity in high-grade serous ovarian cancer: evidence for a stochastic model of proliferation.

Degree: PhD, 2017, University of Cambridge

High-grade serous ovarian cancer (HGSOC) represents the largest and most lethal subtype of ovarian cancers. Chemotherapy is effective at depleting these tumours, sometimes eliminating all… (more)

Subjects/Keywords: ovarian cancer; HGSOC; high-grade serous; stochastic; proliferation; cancer stem cells; stem cells; PDX; xenografts; subcutaneous; EpCAM; slow-cycling; apoptosis; lineage tracing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hall, D. (2017). Phenotypic heterogeneity in high-grade serous ovarian cancer: evidence for a stochastic model of proliferation. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/291331https://www.repository.cam.ac.uk/bitstream/1810/291331/3/b8c0cfac-eea3-4d49-a770-719f6ba1e220_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/5/b8c0cfac-eea3-4d49-a770-719f6ba1e220.zip ; https://www.repository.cam.ac.uk/bitstream/1810/291331/6/Douglas%20Hall%20PhD%20thesis.pdf.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/7/Douglas%20Hall%20PhD%20thesis.pdf.jpg

Chicago Manual of Style (16th Edition):

Hall, Douglas. “Phenotypic heterogeneity in high-grade serous ovarian cancer: evidence for a stochastic model of proliferation.” 2017. Doctoral Dissertation, University of Cambridge. Accessed May 08, 2021. https://www.repository.cam.ac.uk/handle/1810/291331https://www.repository.cam.ac.uk/bitstream/1810/291331/3/b8c0cfac-eea3-4d49-a770-719f6ba1e220_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/5/b8c0cfac-eea3-4d49-a770-719f6ba1e220.zip ; https://www.repository.cam.ac.uk/bitstream/1810/291331/6/Douglas%20Hall%20PhD%20thesis.pdf.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/7/Douglas%20Hall%20PhD%20thesis.pdf.jpg.

MLA Handbook (7th Edition):

Hall, Douglas. “Phenotypic heterogeneity in high-grade serous ovarian cancer: evidence for a stochastic model of proliferation.” 2017. Web. 08 May 2021.

Vancouver:

Hall D. Phenotypic heterogeneity in high-grade serous ovarian cancer: evidence for a stochastic model of proliferation. [Internet] [Doctoral dissertation]. University of Cambridge; 2017. [cited 2021 May 08]. Available from: https://www.repository.cam.ac.uk/handle/1810/291331https://www.repository.cam.ac.uk/bitstream/1810/291331/3/b8c0cfac-eea3-4d49-a770-719f6ba1e220_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/5/b8c0cfac-eea3-4d49-a770-719f6ba1e220.zip ; https://www.repository.cam.ac.uk/bitstream/1810/291331/6/Douglas%20Hall%20PhD%20thesis.pdf.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/7/Douglas%20Hall%20PhD%20thesis.pdf.jpg.

Council of Science Editors:

Hall D. Phenotypic heterogeneity in high-grade serous ovarian cancer: evidence for a stochastic model of proliferation. [Doctoral Dissertation]. University of Cambridge; 2017. Available from: https://www.repository.cam.ac.uk/handle/1810/291331https://www.repository.cam.ac.uk/bitstream/1810/291331/3/b8c0cfac-eea3-4d49-a770-719f6ba1e220_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/5/b8c0cfac-eea3-4d49-a770-719f6ba1e220.zip ; https://www.repository.cam.ac.uk/bitstream/1810/291331/6/Douglas%20Hall%20PhD%20thesis.pdf.txt ; https://www.repository.cam.ac.uk/bitstream/1810/291331/7/Douglas%20Hall%20PhD%20thesis.pdf.jpg

17. Yan, Shunfei. A Genome-wide RNAi screen identifies combinatorial efficacy of CX-5461 with homologous recombination deficiency and Topoisomerase I inhibition in ovarian cancer.

Degree: 2019, University of Melbourne

High-grade serous ovarian cancer (HGSC) is common, with poor prognosis. Limited therapeutic options are available, and the development of new therapies is of high priority.… (more)

Subjects/Keywords: CX-5461; RNA polymerase I; Topoisomerase I; BRCA2; high-throughput screen; synergistic effects; drug combination; high-grade serous ovarian cancer; homologous recombination; DNA damage response

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yan, S. (2019). A Genome-wide RNAi screen identifies combinatorial efficacy of CX-5461 with homologous recombination deficiency and Topoisomerase I inhibition in ovarian cancer. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/228850

Chicago Manual of Style (16th Edition):

Yan, Shunfei. “A Genome-wide RNAi screen identifies combinatorial efficacy of CX-5461 with homologous recombination deficiency and Topoisomerase I inhibition in ovarian cancer.” 2019. Doctoral Dissertation, University of Melbourne. Accessed May 08, 2021. http://hdl.handle.net/11343/228850.

MLA Handbook (7th Edition):

Yan, Shunfei. “A Genome-wide RNAi screen identifies combinatorial efficacy of CX-5461 with homologous recombination deficiency and Topoisomerase I inhibition in ovarian cancer.” 2019. Web. 08 May 2021.

Vancouver:

Yan S. A Genome-wide RNAi screen identifies combinatorial efficacy of CX-5461 with homologous recombination deficiency and Topoisomerase I inhibition in ovarian cancer. [Internet] [Doctoral dissertation]. University of Melbourne; 2019. [cited 2021 May 08]. Available from: http://hdl.handle.net/11343/228850.

Council of Science Editors:

Yan S. A Genome-wide RNAi screen identifies combinatorial efficacy of CX-5461 with homologous recombination deficiency and Topoisomerase I inhibition in ovarian cancer. [Doctoral Dissertation]. University of Melbourne; 2019. Available from: http://hdl.handle.net/11343/228850


Queen Mary, University of London

18. King, Laura Jane. Investigating the transformative potential of different TP53 mutations in cell line models of early high-grade serous ovarian cancer.

Degree: PhD, 2016, Queen Mary, University of London

High-grade serous ovarian cancer (HGSC) is the most common and aggressive form of ovarian cancer, accounting over 60% of cases and up to 90% of… (more)

Subjects/Keywords: serous ovarian cancer; tumourigenesis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

King, L. J. (2016). Investigating the transformative potential of different TP53 mutations in cell line models of early high-grade serous ovarian cancer. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/12859 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775250

Chicago Manual of Style (16th Edition):

King, Laura Jane. “Investigating the transformative potential of different TP53 mutations in cell line models of early high-grade serous ovarian cancer.” 2016. Doctoral Dissertation, Queen Mary, University of London. Accessed May 08, 2021. http://qmro.qmul.ac.uk/xmlui/handle/123456789/12859 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775250.

MLA Handbook (7th Edition):

King, Laura Jane. “Investigating the transformative potential of different TP53 mutations in cell line models of early high-grade serous ovarian cancer.” 2016. Web. 08 May 2021.

Vancouver:

King LJ. Investigating the transformative potential of different TP53 mutations in cell line models of early high-grade serous ovarian cancer. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2016. [cited 2021 May 08]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/12859 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775250.

Council of Science Editors:

King LJ. Investigating the transformative potential of different TP53 mutations in cell line models of early high-grade serous ovarian cancer. [Doctoral Dissertation]. Queen Mary, University of London; 2016. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/12859 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775250


University of Lund

19. Arildsen, Nicolai. Hunting a Silent Killer. Biomolecular Approaches in Ovarian Cancer.

Degree: 2019, University of Lund

Ovarian cancer is a heterogeneous disease and recent advances in improving patient outcome havebeen limited. It is estimated that a woman’s risk of developing ovarian(more)

Subjects/Keywords: Cancer and Oncology; Ovarian cancer; Molecular biology; genetic variant; TP53 mutation; early detection; Drug Screening Assays, Antitumor; bioinformatics; next generation sequencing; NGS; prognostic and predictive biomarkers; ovarian clear cell cancer; high-grade serous ovarian cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Arildsen, N. (2019). Hunting a Silent Killer. Biomolecular Approaches in Ovarian Cancer. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/36538ded-f6d2-4530-bf76-c1b2b50414c3 ; https://portal.research.lu.se/ws/files/61031788/Hunting_a_Silent_Killer_e_spik.pdf

Chicago Manual of Style (16th Edition):

Arildsen, Nicolai. “Hunting a Silent Killer. Biomolecular Approaches in Ovarian Cancer.” 2019. Doctoral Dissertation, University of Lund. Accessed May 08, 2021. https://lup.lub.lu.se/record/36538ded-f6d2-4530-bf76-c1b2b50414c3 ; https://portal.research.lu.se/ws/files/61031788/Hunting_a_Silent_Killer_e_spik.pdf.

MLA Handbook (7th Edition):

Arildsen, Nicolai. “Hunting a Silent Killer. Biomolecular Approaches in Ovarian Cancer.” 2019. Web. 08 May 2021.

Vancouver:

Arildsen N. Hunting a Silent Killer. Biomolecular Approaches in Ovarian Cancer. [Internet] [Doctoral dissertation]. University of Lund; 2019. [cited 2021 May 08]. Available from: https://lup.lub.lu.se/record/36538ded-f6d2-4530-bf76-c1b2b50414c3 ; https://portal.research.lu.se/ws/files/61031788/Hunting_a_Silent_Killer_e_spik.pdf.

Council of Science Editors:

Arildsen N. Hunting a Silent Killer. Biomolecular Approaches in Ovarian Cancer. [Doctoral Dissertation]. University of Lund; 2019. Available from: https://lup.lub.lu.se/record/36538ded-f6d2-4530-bf76-c1b2b50414c3 ; https://portal.research.lu.se/ws/files/61031788/Hunting_a_Silent_Killer_e_spik.pdf

20. Yamanoi, Kouji. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. : 機能的ゲノミクススクリーンにより同定した因子ABHD2の発現低下は、卵巣癌のアノイキス抵抗性、化学療法抵抗性をもたらし、予後不良につながる.

Degree: 博士(医学), 2017, Kyoto University / 京都大学

新制・課程博士

甲第20662号

医博第4272号

Subjects/Keywords: functional genomics screen; shRNA library; Anoikis resistance; High grade serous ovarian cancer

Page 1 Page 2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yamanoi, K. (2017). Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. : 機能的ゲノミクススクリーンにより同定した因子ABHD2の発現低下は、卵巣癌のアノイキス抵抗性、化学療法抵抗性をもたらし、予後不良につながる. (Thesis). Kyoto University / 京都大学. Retrieved from http://hdl.handle.net/2433/227585 ; http://dx.doi.org/10.14989/doctor.k20662

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Yamanoi, Kouji. “Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. : 機能的ゲノミクススクリーンにより同定した因子ABHD2の発現低下は、卵巣癌のアノイキス抵抗性、化学療法抵抗性をもたらし、予後不良につながる.” 2017. Thesis, Kyoto University / 京都大学. Accessed May 08, 2021. http://hdl.handle.net/2433/227585 ; http://dx.doi.org/10.14989/doctor.k20662.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Yamanoi, Kouji. “Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. : 機能的ゲノミクススクリーンにより同定した因子ABHD2の発現低下は、卵巣癌のアノイキス抵抗性、化学療法抵抗性をもたらし、予後不良につながる.” 2017. Web. 08 May 2021.

Vancouver:

Yamanoi K. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. : 機能的ゲノミクススクリーンにより同定した因子ABHD2の発現低下は、卵巣癌のアノイキス抵抗性、化学療法抵抗性をもたらし、予後不良につながる. [Internet] [Thesis]. Kyoto University / 京都大学; 2017. [cited 2021 May 08]. Available from: http://hdl.handle.net/2433/227585 ; http://dx.doi.org/10.14989/doctor.k20662.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Yamanoi K. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. : 機能的ゲノミクススクリーンにより同定した因子ABHD2の発現低下は、卵巣癌のアノイキス抵抗性、化学療法抵抗性をもたらし、予後不良につながる. [Thesis]. Kyoto University / 京都大学; 2017. Available from: http://hdl.handle.net/2433/227585 ; http://dx.doi.org/10.14989/doctor.k20662

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

21. Yamanoi, Kouji. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer.

Degree: 2017, Kyoto University

Subjects/Keywords: functional genomics screen; shRNA library; Anoikis resistance; High grade serous ovarian cancer

Page 1 Page 2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yamanoi, K. (2017). Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. (Thesis). Kyoto University. Retrieved from http://hdl.handle.net/2433/227585

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Yamanoi, Kouji. “Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. ” 2017. Thesis, Kyoto University. Accessed May 08, 2021. http://hdl.handle.net/2433/227585.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Yamanoi, Kouji. “Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. ” 2017. Web. 08 May 2021.

Vancouver:

Yamanoi K. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. [Internet] [Thesis]. Kyoto University; 2017. [cited 2021 May 08]. Available from: http://hdl.handle.net/2433/227585.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Yamanoi K. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. [Thesis]. Kyoto University; 2017. Available from: http://hdl.handle.net/2433/227585

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

22. Lepage, Chloe C. Evaluating the impact diminished SKP1 and CUL1 expression have on chromosome instability and high-grade serous ovarian cancer pathogenesis.

Degree: Biochemistry and Medical Genetics, 2019, University of Manitoba

High-grade serous ovarian cancer (HGSOC) is the most common and lethal ovarian cancer subtype. Chromosome instability (CIN; an increased rate of chromosome gains and losses)… (more)

Subjects/Keywords: High-grade serous ovarian cancer; Chromosome instability; Biochemistry; Genetics; Cancer; SCF complex; Cellular transformation

…solution High-grade serous ovarian cancer Horseradish peroxidase Homologous recombination repair… …i.e. histotypes)2,3. High-grade serous ovarian cancer (HGSOC) is the most… …Pathogenesis of High-Grade Serous Ovarian Cancer (HGSOC) As described above, HGSOC is a… …typically categorized as one of five major histotypes: high-grade serous, low-grade serous… …INTRODUCTION 1.1. OVARIAN CANCER OVERVIEW In Canada, 220,400 new cancer diagnoses occur each year… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lepage, C. C. (2019). Evaluating the impact diminished SKP1 and CUL1 expression have on chromosome instability and high-grade serous ovarian cancer pathogenesis. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/34461

Chicago Manual of Style (16th Edition):

Lepage, Chloe C. “Evaluating the impact diminished SKP1 and CUL1 expression have on chromosome instability and high-grade serous ovarian cancer pathogenesis.” 2019. Masters Thesis, University of Manitoba. Accessed May 08, 2021. http://hdl.handle.net/1993/34461.

MLA Handbook (7th Edition):

Lepage, Chloe C. “Evaluating the impact diminished SKP1 and CUL1 expression have on chromosome instability and high-grade serous ovarian cancer pathogenesis.” 2019. Web. 08 May 2021.

Vancouver:

Lepage CC. Evaluating the impact diminished SKP1 and CUL1 expression have on chromosome instability and high-grade serous ovarian cancer pathogenesis. [Internet] [Masters thesis]. University of Manitoba; 2019. [cited 2021 May 08]. Available from: http://hdl.handle.net/1993/34461.

Council of Science Editors:

Lepage CC. Evaluating the impact diminished SKP1 and CUL1 expression have on chromosome instability and high-grade serous ovarian cancer pathogenesis. [Masters Thesis]. University of Manitoba; 2019. Available from: http://hdl.handle.net/1993/34461

23. Lorena Alves Teixeira. Expressão de BRCA1 e BRCA2 por imuno-histoquímica e prognóstico no câncer de ovário: uma revisão sistemática e meta-análise.

Degree: 2019, University of São Paulo

 O câncer de ovário é a neoplasia maligna ginecológica de maior letalidade no mundo. As proteínas BRCA1 e BRCA2, frequentemente alteradas nos carcinomas epiteliais de… (more)

Subjects/Keywords: Anticorpo; Biomarcador; BRCA1; BRCA2; Carcinoma epitelial de ovário; Expressão proteica; IHQ; Imunoexpressão; Prognóstico; Recombinação homóloga; Sobrevida; Teste imunohistoquímico; Antibody; Biomarker; BRCA1; BRCA2; Breast cancer susceptibility gene 1; Breast cancer susceptibility gene 2; Epithelial ovarian carcinoma; High-grade serous ovarian carcinoma; Homologous recombination; IHC; Immunohistochemistry; Prognostic Protein expression; Survival

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Teixeira, L. A. (2019). Expressão de BRCA1 e BRCA2 por imuno-histoquímica e prognóstico no câncer de ovário: uma revisão sistemática e meta-análise. (Masters Thesis). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/17/17145/tde-04102019-111509/

Chicago Manual of Style (16th Edition):

Teixeira, Lorena Alves. “Expressão de BRCA1 e BRCA2 por imuno-histoquímica e prognóstico no câncer de ovário: uma revisão sistemática e meta-análise.” 2019. Masters Thesis, University of São Paulo. Accessed May 08, 2021. http://www.teses.usp.br/teses/disponiveis/17/17145/tde-04102019-111509/.

MLA Handbook (7th Edition):

Teixeira, Lorena Alves. “Expressão de BRCA1 e BRCA2 por imuno-histoquímica e prognóstico no câncer de ovário: uma revisão sistemática e meta-análise.” 2019. Web. 08 May 2021.

Vancouver:

Teixeira LA. Expressão de BRCA1 e BRCA2 por imuno-histoquímica e prognóstico no câncer de ovário: uma revisão sistemática e meta-análise. [Internet] [Masters thesis]. University of São Paulo; 2019. [cited 2021 May 08]. Available from: http://www.teses.usp.br/teses/disponiveis/17/17145/tde-04102019-111509/.

Council of Science Editors:

Teixeira LA. Expressão de BRCA1 e BRCA2 por imuno-histoquímica e prognóstico no câncer de ovário: uma revisão sistemática e meta-análise. [Masters Thesis]. University of São Paulo; 2019. Available from: http://www.teses.usp.br/teses/disponiveis/17/17145/tde-04102019-111509/


University of Toronto

24. Medrano, Mauricio. Integrated Functional and Genomic Analysis of High-Grade Serous Ovarian Cancer.

Degree: PhD, 2015, University of Toronto

 Epithelial ovarian cancer is the fifth-leading cause of cancer-related death for women in North America and is responsible for over 100 000 deaths/year worldwide (Ferlay… (more)

Subjects/Keywords: cancer; CD151; genomics; high-grade; ovarian; rna interference; 0307

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Medrano, M. (2015). Integrated Functional and Genomic Analysis of High-Grade Serous Ovarian Cancer. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/79747

Chicago Manual of Style (16th Edition):

Medrano, Mauricio. “Integrated Functional and Genomic Analysis of High-Grade Serous Ovarian Cancer.” 2015. Doctoral Dissertation, University of Toronto. Accessed May 08, 2021. http://hdl.handle.net/1807/79747.

MLA Handbook (7th Edition):

Medrano, Mauricio. “Integrated Functional and Genomic Analysis of High-Grade Serous Ovarian Cancer.” 2015. Web. 08 May 2021.

Vancouver:

Medrano M. Integrated Functional and Genomic Analysis of High-Grade Serous Ovarian Cancer. [Internet] [Doctoral dissertation]. University of Toronto; 2015. [cited 2021 May 08]. Available from: http://hdl.handle.net/1807/79747.

Council of Science Editors:

Medrano M. Integrated Functional and Genomic Analysis of High-Grade Serous Ovarian Cancer. [Doctoral Dissertation]. University of Toronto; 2015. Available from: http://hdl.handle.net/1807/79747


Universiteit Utrecht

25. Groeneweg, J.W. Molecular targets in serous gynecologic cancers.

Degree: 2015, Universiteit Utrecht

 In this thesis we describe a series of studies assessing the effectiveness of targeted therapeutics that inhibit Notch signaling or the HER2 receptor in serous(more)

Subjects/Keywords: Ovarian cancer; uterine serous carcinoma; HER2 inhibition; Notch inhibition

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Groeneweg, J. W. (2015). Molecular targets in serous gynecologic cancers. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/304747

Chicago Manual of Style (16th Edition):

Groeneweg, J W. “Molecular targets in serous gynecologic cancers.” 2015. Doctoral Dissertation, Universiteit Utrecht. Accessed May 08, 2021. http://dspace.library.uu.nl:8080/handle/1874/304747.

MLA Handbook (7th Edition):

Groeneweg, J W. “Molecular targets in serous gynecologic cancers.” 2015. Web. 08 May 2021.

Vancouver:

Groeneweg JW. Molecular targets in serous gynecologic cancers. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2015. [cited 2021 May 08]. Available from: http://dspace.library.uu.nl:8080/handle/1874/304747.

Council of Science Editors:

Groeneweg JW. Molecular targets in serous gynecologic cancers. [Doctoral Dissertation]. Universiteit Utrecht; 2015. Available from: http://dspace.library.uu.nl:8080/handle/1874/304747


University of Western Ontario

26. Kahramanoğlu, Zeynep Gülsüm. Mechanisms underlying chemotherapy-induced vascular proliferation in ovarian cancer.

Degree: 2017, University of Western Ontario

Ovarian cancer is a leading cause of gynecological cancer-related death in Canadian women. Ovarian cancer is managed through surgical cytoreduction and carboplatin-based chemotherapy. Unfortunately, most… (more)

Subjects/Keywords: Serous ovarian cancer; angiogenesis; chemotherapy; carboplatin; vascular proliferation; Neoplasms

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kahramanoğlu, Z. G. (2017). Mechanisms underlying chemotherapy-induced vascular proliferation in ovarian cancer. (Thesis). University of Western Ontario. Retrieved from https://ir.lib.uwo.ca/etd/4709

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kahramanoğlu, Zeynep Gülsüm. “Mechanisms underlying chemotherapy-induced vascular proliferation in ovarian cancer.” 2017. Thesis, University of Western Ontario. Accessed May 08, 2021. https://ir.lib.uwo.ca/etd/4709.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kahramanoğlu, Zeynep Gülsüm. “Mechanisms underlying chemotherapy-induced vascular proliferation in ovarian cancer.” 2017. Web. 08 May 2021.

Vancouver:

Kahramanoğlu ZG. Mechanisms underlying chemotherapy-induced vascular proliferation in ovarian cancer. [Internet] [Thesis]. University of Western Ontario; 2017. [cited 2021 May 08]. Available from: https://ir.lib.uwo.ca/etd/4709.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kahramanoğlu ZG. Mechanisms underlying chemotherapy-induced vascular proliferation in ovarian cancer. [Thesis]. University of Western Ontario; 2017. Available from: https://ir.lib.uwo.ca/etd/4709

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Illinois – Chicago

27. Dimple A. Modi (7941227). Modeling Precursor Lesions by Targeting Key Molecular Pathways in High-Grade Serous Ovarian Cancer.

Degree: 2016, University of Illinois – Chicago

High-Grade Serous Ovarian Cancer (HGSC) is the deadliest gynecological malignancy that affects women worldwide. A major confounding factor in the field is that the epithelial… (more)

Subjects/Keywords: Uncategorized; gonadotropins; serous ovarian cancer; PAX2; p53; fallopian tube; dendrimer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

(7941227), D. A. M. (2016). Modeling Precursor Lesions by Targeting Key Molecular Pathways in High-Grade Serous Ovarian Cancer. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/20958

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

(7941227), Dimple A. Modi. “Modeling Precursor Lesions by Targeting Key Molecular Pathways in High-Grade Serous Ovarian Cancer.” 2016. Thesis, University of Illinois – Chicago. Accessed May 08, 2021. http://hdl.handle.net/10027/20958.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

(7941227), Dimple A. Modi. “Modeling Precursor Lesions by Targeting Key Molecular Pathways in High-Grade Serous Ovarian Cancer.” 2016. Web. 08 May 2021.

Vancouver:

(7941227) DAM. Modeling Precursor Lesions by Targeting Key Molecular Pathways in High-Grade Serous Ovarian Cancer. [Internet] [Thesis]. University of Illinois – Chicago; 2016. [cited 2021 May 08]. Available from: http://hdl.handle.net/10027/20958.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

(7941227) DAM. Modeling Precursor Lesions by Targeting Key Molecular Pathways in High-Grade Serous Ovarian Cancer. [Thesis]. University of Illinois – Chicago; 2016. Available from: http://hdl.handle.net/10027/20958

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

28. Wu, Ren-Chin. MOLECULAR GENETICS OF GYNECOLOGIC CANCERS.

Degree: 2014, Johns Hopkins University

 The thesis is focused on the molecular genetics of gynecologic cancers, specifically uterine serous carcinoma (USC) and ovarian clear cell carcinoma (OCCC), two relatively uncommon… (more)

Subjects/Keywords: uterine serous carcinoma; TERT; telomere; clear cell carcinoma; ovarian cancer; endometrial cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wu, R. (2014). MOLECULAR GENETICS OF GYNECOLOGIC CANCERS. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/37128

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wu, Ren-Chin. “MOLECULAR GENETICS OF GYNECOLOGIC CANCERS.” 2014. Thesis, Johns Hopkins University. Accessed May 08, 2021. http://jhir.library.jhu.edu/handle/1774.2/37128.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wu, Ren-Chin. “MOLECULAR GENETICS OF GYNECOLOGIC CANCERS.” 2014. Web. 08 May 2021.

Vancouver:

Wu R. MOLECULAR GENETICS OF GYNECOLOGIC CANCERS. [Internet] [Thesis]. Johns Hopkins University; 2014. [cited 2021 May 08]. Available from: http://jhir.library.jhu.edu/handle/1774.2/37128.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wu R. MOLECULAR GENETICS OF GYNECOLOGIC CANCERS. [Thesis]. Johns Hopkins University; 2014. Available from: http://jhir.library.jhu.edu/handle/1774.2/37128

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

29. Gornjec, Andreja. Določanje mutacij v genih brca1/2 iz citološkega materiala pri raku jajčnikov, jajcevodov in primarnem peritonealnem seroznem karcinomu.

Degree: 2020, Univerza v Mariboru

Izhodišče Serozni rak jajčnikov je slabo ozdravljiva bolezen. Zdravljenje ponovitve bolezni je odvisno od prisotnosti BRCA1/2 mutacije, kajti samo bolnice z znano BRCA mutacijo so… (more)

Subjects/Keywords: visoko maligni serozni rak jajčnikov; BRCA1/2 mutacija; testiranje BRCA mutacij; citološki vzorec,; high-grade serous cancer; BRCA1/2 mutation; BRCA1/2 mutation testing; cytological samples

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gornjec, A. (2020). Določanje mutacij v genih brca1/2 iz citološkega materiala pri raku jajčnikov, jajcevodov in primarnem peritonealnem seroznem karcinomu. (Doctoral Dissertation). Univerza v Mariboru. Retrieved from https://dk.um.si/IzpisGradiva.php?id=73473 ; https://dk.um.si/Dokument.php?id=140922&dn= ; https://plus.si.cobiss.net/opac7/bib/22760195?lang=sl

Chicago Manual of Style (16th Edition):

Gornjec, Andreja. “Določanje mutacij v genih brca1/2 iz citološkega materiala pri raku jajčnikov, jajcevodov in primarnem peritonealnem seroznem karcinomu.” 2020. Doctoral Dissertation, Univerza v Mariboru. Accessed May 08, 2021. https://dk.um.si/IzpisGradiva.php?id=73473 ; https://dk.um.si/Dokument.php?id=140922&dn= ; https://plus.si.cobiss.net/opac7/bib/22760195?lang=sl.

MLA Handbook (7th Edition):

Gornjec, Andreja. “Določanje mutacij v genih brca1/2 iz citološkega materiala pri raku jajčnikov, jajcevodov in primarnem peritonealnem seroznem karcinomu.” 2020. Web. 08 May 2021.

Vancouver:

Gornjec A. Določanje mutacij v genih brca1/2 iz citološkega materiala pri raku jajčnikov, jajcevodov in primarnem peritonealnem seroznem karcinomu. [Internet] [Doctoral dissertation]. Univerza v Mariboru; 2020. [cited 2021 May 08]. Available from: https://dk.um.si/IzpisGradiva.php?id=73473 ; https://dk.um.si/Dokument.php?id=140922&dn= ; https://plus.si.cobiss.net/opac7/bib/22760195?lang=sl.

Council of Science Editors:

Gornjec A. Določanje mutacij v genih brca1/2 iz citološkega materiala pri raku jajčnikov, jajcevodov in primarnem peritonealnem seroznem karcinomu. [Doctoral Dissertation]. Univerza v Mariboru; 2020. Available from: https://dk.um.si/IzpisGradiva.php?id=73473 ; https://dk.um.si/Dokument.php?id=140922&dn= ; https://plus.si.cobiss.net/opac7/bib/22760195?lang=sl

30. Alrubaish, Sarah. Role of zinc transporter LIV-1 protein in high-grade serous ovarian cancer.

Degree: 2018, Université de Montréal

Subjects/Keywords: Invasion cellulaire; LIV-1; Migration cellulaire; Cancer de l'ovaire épithélial; Carcinome séreux de haut grade; Cell invasion; Cell migration; Epithelial ovarian cancer; High-grade serous carcinoma (HGSC); Health Sciences - Oncology / Sciences de la santé - Oncologie (UMI : 0992)

…from borderline tumours. 8,9 1.1.3.1 Epithelial ovarian cancer subtypes A) High-grade… …staining of different histological types of epithelial ovarian cancer. (A) High-grade… …Inducible Protein 45 GSK-3β : Glycogen Synthase Kinase 3 Beta HGSC : High-Grade Serous… …epithelial ovarian cancer… …Factor Receptor EMT : Epithelial-Mesenchymal Transition EOC : Epithelial Ovarian Cancer… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alrubaish, S. (2018). Role of zinc transporter LIV-1 protein in high-grade serous ovarian cancer. (Thesis). Université de Montréal. Retrieved from http://hdl.handle.net/1866/21364

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Alrubaish, Sarah. “Role of zinc transporter LIV-1 protein in high-grade serous ovarian cancer.” 2018. Thesis, Université de Montréal. Accessed May 08, 2021. http://hdl.handle.net/1866/21364.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Alrubaish, Sarah. “Role of zinc transporter LIV-1 protein in high-grade serous ovarian cancer.” 2018. Web. 08 May 2021.

Vancouver:

Alrubaish S. Role of zinc transporter LIV-1 protein in high-grade serous ovarian cancer. [Internet] [Thesis]. Université de Montréal; 2018. [cited 2021 May 08]. Available from: http://hdl.handle.net/1866/21364.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Alrubaish S. Role of zinc transporter LIV-1 protein in high-grade serous ovarian cancer. [Thesis]. Université de Montréal; 2018. Available from: http://hdl.handle.net/1866/21364

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [2354]

.